This article is available online at http://www.jlr.org Both phthiocerol/phthiodiolone dimycocerosate (PDIM) esters and phenolic glycolipids (PGLs) are dimycocerosate esters (DIMs) produced by pathogenic mycobacteria. PDIMs were originally isolated from Mycobacterium tuberculosis (1)(2)(3)(4) and are specifi c tuberculosis biomarkers ( 5, 6 ). They are among the most abundant lipids in the cell wall of various pathogenic mycobacteria, including M. tuberculosis , M. bovis , M. leprae , M. kansasii , M. microti , and M. marinum ( 7-10 ), which are known to synthesize a range of complex highmolecular-mass lipids ( 7 ). PGLs are produced by the same set of pathogenic mycobacteria species, except that in M. tuberculosis only a subset of clinical isolates belonging to the W-Beijing family ( 11 ) produces PGLs.Phthiocerol and phenolphthiocerol and other lipids such as mycolic acids and methyl-branched FAs in cell wall are among those that have been most extensively studied in terms of their biosynthesis and the role in M. tuberculosis virulence in vivo ( 12 ). In pathogenesis, the role of PDIMs of M. tuberculosis was recognized by the studies that identifi ed that mutants of M. tuberculosis were unable to either produce or properly localize PDIMs to the cell envelopeand that demonstrated that PDIM-defi cient strains were attenuated in animal models of infection ( 8,11,(13)(14)(15)(16)(17). Recently, M. tuberculosis and its close pathogenic relative M. marinum were reported to manipulate macrophage recruitment through coordinated use of membrane PDIM and PGLs to initiate infections ( 18 ). However, the precise role of these molecules in the course of infection remains largely unknown, and their role in the multiplication of mycobacteria from the tuberculosis complex in organs other than the lungs is also unclear.